Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Major Healthcare Service Provider Cardinal Health Issues Upbeat Outlook, Shares Rise

By Vandana Singh
November 3, 9:05 AM
Cardinal Health Inc (NYSE: CAH) reported 

CAH

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Implants And Joint Replacement Company Stryker Tightens Annual Forecast On ‘Positive Procedural Trends’

By Vandana Singh
November 3, 8:22 AM
Stryker Corporation (NYSE: SYK) reported Q3 sales of $4.9 billion, up 9.6% Y/Y (+9.3% in constant currency), beating the consen

SYK

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • News

Obesity And Diabetes Drugs Demand Help Distributor Cencora Propel Revenue In Q3

By Vandana Singh
November 2, 3:49 PM
Cencora Inc's (NYSE: COR), formerly AmerisourceBergen Corporation, 

COR

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?

By Vandana Singh
November 2, 2:50 PM
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and 

BAX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Earnings
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Dental Firm Envista Q3 Performance Disappoints, Uncertainty, Macro Headwinds To In Short Term

By Vandana Singh
November 2, 2:18 PM
Wednesday, after close, Envista Holdings Corporation (NYSE: NVST) reported Q3<

NVST

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Regeneron’s Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug

By Vandana Singh
November 2, 1:53 PM
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned Q3 adjusted EPS of $11.59, up 4% Y/Y, beating the $10.77 Street estimate

REGN

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks

Cutting-Edge Cannabis Products On The Horizon As Biotech Co. Funds New Research

By Jelena Martinovic
November 2, 1:21 PM
Synaptogenix, Inc. (NASDAQ: SNPX) has teamed up with Cannasoul Analytics Ltd.

SNPX

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News

Why Is Blood Cancer Focused Arcellx Stock Trading Higher Today?

By Vandana Singh
November 2, 12:39 PM
Arcellx Inc (NASDAQ: ACLX) announced that new clinical data from its Phase 1 study of CART-ddBCMA in patients with relapsed or refra

ACLX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Is Cancer Firm Panbela Therapeutics Stock Trading Higher Today?

By Vandana Singh
November 2, 12:36 PM
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading higher after the company announced the publication of preclinical and clinical data from studies of CPP-1X (also known as α-Difluoromethylornithine (DFMO) or Eflornithine) in

PBLA

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today?

By Vandana Singh
November 2, 12:30 PM
Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has 

OTLK

Posts pagination

Previous 1 … 127 128 129 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service